Scarborough Advisors’s Amgen AMGN Stock Holding History

Scarborough Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,612	Closed	-$567K	–	179
2026 Q1	$567K	Sell	1,612 -118	-7%	-$42.1K	0.06%	97
2025 Q4	$566K	Sell	1,730 -1	-0.1%	-$317	0.1%	64
2025 Q3	$488K	Buy	1,731 +1	+0.1%	+$290	0.09%	63
2025 Q2	$483K	Hold	1,730	–	–	0.1%	57
2025 Q1	$539K	Sell	1,730 -64	-4%	-$18.9K	0.08%	82
2024 Q4	$468K	Sell	1,794 -40	-2%	-$11.9K	0.07%	86
2024 Q3	$591K	Buy	1,834 +83	+5%	+$27.1K	0.1%	55
2024 Q2	$547K	Buy	1,751 +11	+0.6%	+$3.23K	0.23%	33
2024 Q1	$495K	Sell	1,740 -17	-1%	-$4.97K	0.23%	29
2023 Q4	$506K	Buy	1,757 +23	+1%	+$6.27K	0.1%	53
2023 Q3	$466K	Buy	+1,734	New	+$433K	0.11%	52

Other funds holding AMGN

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FFM

Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

Scarborough Advisors's AMGN Position: Q2 2026 in Review

Scarborough Advisors sold out of Amgen (AMGN) in Q2 2026, closing a stake of 1,612 shares — an estimated $567K sold.

Scarborough Advisors first reported a position in AMGN in Q3 2023 and held it in 11 quarters. The position peaked at $591K in Q3 2024. 1,343 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Scarborough Advisors reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
Scarborough Advisors sold 1,612 Amgen shares in Q2 2026, an estimated $567K.
Scarborough Advisors first reported a position in Amgen in Q3 2023 and held it in 11 quarters.
Scarborough Advisors's Amgen position peaked at $591K in Q3 2024.
1,343 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Scarborough Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.